Latest Convertible Note Funding News

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

Audio Pixels Holdings has made significant technical strides in its MEMS-based Digital Sound Reconstruction technology while securing $1.25 million in new convertible note funding. Despite progress, the company remains suspended from ASX pending further capital raises.

I Synergy Group Limited reported a mixed quarterly cash flow for Q3 2025, highlighting ongoing operational cash outflows but securing financing to extend its runway to just under two quarters.

Anax Metals has made significant progress on its Whim Creek Copper-Zinc project, securing a waste rock processing agreement and continuing efforts to finalize project financing.

Harvest Technology Group reported improved EBITDA and secured new customers across mining, defence, and border control sectors in Q1 FY2026, supported by $2.13 million raised through convertible notes and loans.

The Calmer Co has reported a robust 26% increase in quarterly sales, driven by strong growth in Australia and the US, alongside a significant 39% reduction in cash used in operations, signaling clear progress toward profitability.

The Calmer Co. International Limited has delivered its strongest quarter yet, with revenue surging 26% to $2.4 million and operating cash outflows dropping to a historic low. Strategic growth across retail, e-commerce, and B2B channels underpins its confident path to breakeven.

Audio Pixels Holdings has raised A$1.25 million through unsecured convertible notes from sophisticated investors, with the Chairman’s company poised to invest up to A$2 million pending shareholder approval. This funding boost aims to extend the company’s working capital runway and support its strategic goals.

Morella Corporation has locked in A$1.4 million in convertible note funding from key shareholders and directors, strengthening its financial position to advance critical minerals exploration and acquisitions.

Mesoblast Limited reports a 69% jump in net revenues from its pioneering cell therapy Ryoncil in Q1 FY2026, propelled by expanded physician adoption and new reimbursement pathways. The company also secures convertible note funding and plans pivotal adult trials.

Excite Technology Services has raised $2.1 million through convertible notes from institutional investors, including key backer Belgravia Strategic Equities, to fund cost restructuring and operational improvements.

AssetOwl Limited has locked in a $281,654 convertible note funding from a related party, adding to its financing options as it navigates shareholder approval and potential share dilution.